  There is a clear need for new strategies of leishmaniasis<disease> treatment. This work was conducted to evaluate the efficacy of the co-administration of tamoxifen and meglumine antimoniate ( Sb A randomised controlled pilot clinical trial was conducted to evaluate the efficacy and safety of oral ( 40 mg/day for 20 days) or topical tamoxifen ( 0.1 % tamoxifen citrate for 20 days) combined with meglumine antimoniate ( 20 mg Sb A total of 38 subjects were included in the trial , 15 were treated with standard Sb In the doses and schemes used in this study , co-administration of oral tamoxifen and Sb